A well-known Melrose bar hangout is being reborn next month, as the former Darkroom makes way for a new lounge called APB, a shortening not of “all-points bulletin” but of All Plant Based. What ...
At 9 PM, the premiere of new cop drama APB (1.5) matched its 24: Legacy lead-in. That was a solid showing for a series with none of 24: Legacy‘s name recognition and fraction of its marketing, no ...
If fraught existence were a town, All Points Bulletin would run it. After a $100 million five-year development from the team behind Crackdown, APB was released, panned, shut down, resurrected and ...
Free-to-play, massively multiplayer online action game APB: Reloaded, which was released for Windows PC in 2011, is coming to PlayStation 4 and Xbox One this year, Deep Silver, Reloaded Games and The ...
APB is vapid. It’s a game so concerned with how it looks and the personality it puts out that it never bothers to actually have any real personality in the first place. Smoke and mirrors is one way to ...
After months of speculation, down-and-out MMO APB finally has a new owner. K2 Networks is it. GamesIndustry.biz reports that a sum of around £1.5 million sealed the deal. Who? The outfit that takes ...
All Hyperion Solutions Corp. wanted was a fair fight. That’s what it got, more or less, when it vaulted over Oracle to take the performance crown in an aging industry benchmark that had been all but ...
Heads up, APB: Reloaded players; the game's patch 1.7: A New Breed Part One is now live, so it's time once again to lock and load. This rather sizeable update brings quite a few new features with it, ...
A gamer from the Midwest, Megan has loved video games since feeling the rush of beating a final boss for the first time. When not writing for Dualshockers, she can be found thinking up crazy amounts ...
Apic Bio Receives FDA Fast Track Designation for APB-102 for the Treatment of Patients with SOD1 ALS
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apic Bio, Inc., an innovative gene therapy company developing novel treatment options for patients with rare genetic diseases, today announced that the U.S. Food and ...
APB-A1 targets the clinically validated CD40L/CD40 biology which is central to a wide range of attractive neuroimmune indications APB-A1 is a novel and differentiated biotherapeutic with strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback